Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245462.RA20EUwrgAQ6tkdkGjHCiJxGl06E-S3pHJioG0A2-XzFk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245462.RA20EUwrgAQ6tkdkGjHCiJxGl06E-S3pHJioG0A2-XzFk130_assertion type Assertion NP1245462.RA20EUwrgAQ6tkdkGjHCiJxGl06E-S3pHJioG0A2-XzFk130_head.
- NP1245462.RA20EUwrgAQ6tkdkGjHCiJxGl06E-S3pHJioG0A2-XzFk130_assertion description "[In the present study, our results indicated that lncRNA MALAT1 was highly expressed in pancreatic cancer compared with adjacent non-cancerous tissues (P?<?0.001), and positively correlated with clinical stage (early stages vs. advanced stages, P?<?0.001), tumor size (<2 vs. ?2�cm, P?=?0.004), lymph node metastasis (negative vs. positive, P?<?0.001), and distant metastasis (absent vs. present, P?=?0.001) in pancreatic cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245462.RA20EUwrgAQ6tkdkGjHCiJxGl06E-S3pHJioG0A2-XzFk130_provenance.
- NP1245462.RA20EUwrgAQ6tkdkGjHCiJxGl06E-S3pHJioG0A2-XzFk130_assertion evidence source_evidence_literature NP1245462.RA20EUwrgAQ6tkdkGjHCiJxGl06E-S3pHJioG0A2-XzFk130_provenance.
- NP1245462.RA20EUwrgAQ6tkdkGjHCiJxGl06E-S3pHJioG0A2-XzFk130_assertion SIO_000772 25481511 NP1245462.RA20EUwrgAQ6tkdkGjHCiJxGl06E-S3pHJioG0A2-XzFk130_provenance.
- NP1245462.RA20EUwrgAQ6tkdkGjHCiJxGl06E-S3pHJioG0A2-XzFk130_assertion wasDerivedFrom befree-2016 NP1245462.RA20EUwrgAQ6tkdkGjHCiJxGl06E-S3pHJioG0A2-XzFk130_provenance.
- NP1245462.RA20EUwrgAQ6tkdkGjHCiJxGl06E-S3pHJioG0A2-XzFk130_assertion wasGeneratedBy ECO_0000203 NP1245462.RA20EUwrgAQ6tkdkGjHCiJxGl06E-S3pHJioG0A2-XzFk130_provenance.